Baxter Announces Winners of "Picture Your Tomorrow, Today" Global Photo Contest

Istanbul , Turkey, June 2 , 2008 – Baxter Healthcare Corporation today announced the winners of the “Picture Your Tomorrow, Today” global photo contest at the XXVIII International Congress of the World Federation of Hemophilia (WFH) in Istanbul, which is taking place June 1-5. Contest entrants included people with hemophilia A from eight different countries who submitted photographs with explanations about what they believe their future holds. Alex Lipov of the United Kingdom earned first place in the 14-years-of-age-and-younger category, while Curtis Spicer of Canada took first place in the 15-years-of-age-and-older category. Both contestants were awarded trips to the WFH Congress. The two grand-prize-winning photographs, along with eight honorable mentions, will be displayed in Baxter’s booth at the WFH Congress.

“We are making great progress in hemophilia care, allowing people with hemophilia to do more than ever before, which is reinforced by these poignant winning photographs,” said Mark Skinner, president, World Federation of Hemophilia. “The winners and their compositions embody the benefits of access to treatment, which the WFH is committed to globally.”

The submission from Lipov, winner of the 14-years-of-age-and-younger category, features a family kayaking trip in Menorca, Spain. His explanation notes: “In the future, I will be adventurous … I want to travel to many places around the world … I see my life as an exciting journey that will never stop.”

Spicer, winner of the 15-years-of-age-and-older category, submitted a photo that illustrates a group of ducks and pigeons feeding on the ground, with one pigeon that breaks free from the pack and begins to fly. In his corresponding essay, Spicer likens himself to that bird, recalling that after factor VIII concentrate for hemophilia became available, “It let me spread my wings for the first time … tomorrow, the treatment for hemophilia will be like the wings on the bird. It will let us soar to reach our true potential.”

“In my lifetime, I’ve witnessed incredible advancements in hemophilia care, allowing me to never be held back by my hemophilia, evidenced by my career as a race-car driver,” said Curtis Spicer. “This contest enabled me to reflect on my opportunities and accomplishments and I encourage others to live life to the fullest.”

About “Picture Your Tomorrow, Today”

To recognize and celebrate advancements in the hemophilia community, Baxter conducted “Picture Your Tomorrow, Today,” a global photo contest that encouraged participants to portray a photographic vision of what they believe the future holds for them, along with a corresponding essay.

Photographs were judged by an independent international panel of professional photographers. The panel evaluated entries based on their relevance to the contest theme, “Picture Your Tomorrow, Today,” level of creativity and original thought conveyed through the photograph; and technical elements of the photograph, including focus, composition, sharpness and clarity. Winners were selected from two categories: 14 years of age and younger and 15 years of age and older.

In addition to the two grand prizes, Baxter awarded the following individuals with honorable mention prizes:

• Brett Clement, United States of America
• Francisco Diaz Alamo, Spain
• Henry Dodson, United Kingdom
• Meech Kean, Canada
• Jeson Lee, Taiwan
• Alex Little, Canada
• Miguel Angel Martín, Spain
• Patrick Ryan, United States of America

“We are extremely impressed with the quality of entries and level of community interest in this year’s contest,” said David Holliday, vice president of Baxter’s global hemophilia business. “We believe that these photographs truly capture the spirit and evolution of the community, and we have been proud to provide our continued support to people living with hemophilia.”

To learn more about “Picture Your Tomorrow, Today” and to view the winning entries, please visit www.pictureyourtomorrow.com.

About Hemophilia A

People with hemophilia A do not produce adequate amounts of factor VIII, which is necessary for blood to effectively clot. If untreated, patients with severe hemophilia A have a greatly reduced life expectancy. According to the World Federation of Hemophilia, more than 400,000 people in the world have hemophilia.

Baxter Hemophilia Research and Development

Baxter is a global leader in hemophilia therapy, with innovations that span 40 years. Through its own scientific expertise and strategic collaborations, Baxter is applying novel technologies that will pioneer the next generation of hemophilia therapies. The company is investigating ways to provide less invasive dosing techniques, longer acting therapies that require less frequent infusions, and reduce the potential for inhibitor formation to help improve the lives of people with hemophilia.

About Baxter

Baxter Healthcare Corporation is the principal U.S. operating subsidiary of Baxter International Inc. (NYSE:BAX). Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with the treatment of complex medical conditions, including cancer, hemophilia, immune disorders, kidney disease and trauma. The company applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.

Baxter is a trademark of Baxter International Inc.